DSRLF (DSRLF) Stock Price & Analysis
DSRLF (DSRLF) rose 0.00% to USD 79.99 as of July 25, 2026 at 02:22 UTC, according to Nexqual real-time market data.
DSRLF last closed at USD 79.99; the session ranged USD 77.25–81.9 on volume of 3,300 shares. Market capitalization is $3.96B, with a 52-week range of USD 66.5–107.68 (PNK). Source: Nexqual, July 25, 2026 at 02:22 UTC.
Key Statistics (as of July 25, 2026 at 02:22 UTC)
| Price | USD 79.99 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 79.99 |
| Open | USD 81.9 |
| Day Range | USD 77.25 – 81.9 |
| 52-Week Range | USD 66.5 – 107.68 |
| Volume | 3,300 shares |
| Market Cap | $3.96B |
| Exchange | PNK |
Technical Analysis (DSRLF)
Nexqual's technical model rates DSRLF "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of July 25, 2026 at 02:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 49.04 (neutral) |
| vs SMA50 | Above (USD 76.65) |
| MACD | 0.8 (positive) |
Analyst Ratings (DSRLF)
Wall Street analysts rate DSRLF "None", per Nexqual as of July 25, 2026 at 02:22 UTC.
| Consensus Rating | None |
|---|
Earnings (DSRLF)
| Next Earnings Date | 2026-08-06 |
|---|---|
| Revenue Estimate | $313.74M |
Source: Nexqual, July 25, 2026 at 02:22 UTC.
Financials & Fundamentals (DSRLF)
| Total Revenue | $1.17B |
|---|---|
| Revenue Growth (YoY) | -8.30% |
| Gross Margin | +64.97% |
| Operating Margin | +20.56% |
| Profit Margin | +12.11% |
| ROE | +8.55% |
| Debt / Equity | 47.5 |
| Total Debt | $711.00M |
Source: Nexqual, July 25, 2026 at 02:22 UTC.
Financial Health Score (DSRLF)
Nexqual rates DSRLF's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 02:22 UTC.
| Growth | Mixed — Revenue +0.8% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 65%, operating 21% |
| Balance Sheet | Solid — Debt/Equity 0.5x |
| Cash Flow | Solid — Operating cash flow $330M |
| Efficiency | Mixed — ROE 9%, ROA 6.4% |
Ownership (DSRLF)
| Insider Ownership | +57.56% |
|---|---|
| Institutional Ownership | +14.53% |
| Shares Outstanding | 49.47M |
| Float | 23.15M |
Source: Nexqual, July 25, 2026 at 02:22 UTC.
Leadership (DSRLF)
DSRLF is led by Carlo Rosa (age 59), CEO, GM & Executive Director, per Nexqual as of July 25, 2026 at 02:22 UTC.
| CEO, GM & Executive Director | Carlo Rosa (age 59) |
|---|---|
| Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director | Chen Menachem Even (age 62) |
| Chief Financial Officer | Alberto Donati (age 38) |
| Chief Scientific Officer | Fabrizio Piercarlo Bonelli |
| Corporate Vice President of Communication, ESG & Investor Relations | Riccardo Fava |
Major Backers & Investors (DSRLF)
Notable institutional backers of DSRLF include Goldman Sachs, Brown Advisory Fd.s-Brown Advisory - WMC Strategic European Eqy. Fd., abrdn World Healthcare Fund, according to Nexqual as of July 25, 2026 at 02:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Goldman Sachs | 3.16% |
| Brown Advisory Fd.s-Brown Advisory - WMC Strategic European Eqy. Fd. | 0.32% |
| abrdn World Healthcare Fund | 0.26% |
| WisdomTree Trust-WisdomTree Europe Hedged Equity Fund | 0.25% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.6% |
| BlackRock | 1.02% |
Source: Nexqual, July 25, 2026 at 02:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BMXMF | Biomerieux 69 Marcy L'Etoile | USD 78.99 | ▼ 1.64% |
| GNNDY | GN Store Nord A/S | USD 41.75 | ▼ 0.5% |
| ERFSF | Eurofins Scientific Nante | USD 74.02 | ▼ 8.13% |
| SSMXY | Sysmex Corp. | USD 9.29 | ▼ 1.9% |
| LZAGF | Lonza Group AG | USD 675.41 | ▲ 2.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:22 UTC. This page is informational and not investment advice.